When quality control of maternal and infant products shifts from single-point inspection to full-lifecycle traceability, the industry's safety logic is being rewritten. A recent symposium held in Changxing, Zhejiang, brought together experts from pharmaceuticals GMP, food safety, medical devices, cosmetics, pest control, and third-party testing institutions to calibrate the development direction for hygiene and maternal-infant products across three risk dimensions: physical, chemical, and biological. The signals from this cross-industry dialogue deserve attention from the entire textile and nonwovens supply chain.
Risk Mapping: From Fragmented Responses to Systematic Governance
At the symposium, Tian Xiaohui, R&D general manager of Jinsan Group, proposed a three-dimensional risk traceability matrix of "risk type × product scenario × global regulations," with the core logic of using consumer safety as the "endpoint" to reverse-engineer product design. This means safety control should not stop at factory inspection but extend upstream to raw material procurement and R&D. For upstream suppliers, this is not just compliance pressure but implies that order thresholds will gradually tilt toward risk management capabilities.
Experts from Mettler-Toledo shared a "five-line defense" approach for foreign object control: source prevention, process leak prevention, online detection, reliable rejection, trend warning, and event traceability. This closed-loop thinking applies equally to defect control in nonwovens production. Another expert proposed management standards for visible defects, addressing the long-standing reliance on manual visual inspection in sanitary product surface quality.
Chemical and Biological Risks: Invisible Lines Need Cross-Industry Learning
Chemical risk sources are often hidden. A R&D engineer from Hangzhou老爸评测 pointed out that risk substances may originate from indirect suppliers, direct suppliers, or the product manufacturer itself. He advised companies to move from "compliance" to multi-layer monitoring, extending from targeted testing to non-targeted screening. For buyers, this means supplier audits should not only check test reports but also examine raw material traceability systems and non-targeted screening capabilities.
On biological risks, a senior engineer from Guangzhou Testing and Inspection Group elaborated on the full-lifecycle prevention chain from R&D design to consumer use. A technical manager from a pest control consultancy emphasized that "pest control is not a cleaning issue" but a systemic risk, with a scientific IPM system covering physical barriers, environmental management, monitoring, and response. These cross-industry experiences are also instructive for cleanroom management in textile workshops.
Public Opinion Risk: Compliance Does Not Equal Safety
Sun Xiangfei, associate professor and dean of the New Media Data Research Institute at East China University of Political Science and Law, proposed that product compliance does not equal public opinion safety; risks do not stop at the factory gate, and perceptibility determines explosive power. In the age of social media, a small quality complaint can quickly escalate into a brand crisis. This means companies need to establish public opinion monitoring and response mechanisms, integrating quality risk and public opinion risk governance. For export-oriented enterprises, sensitivity to public opinion in different cultural contexts should also be considered.
Cross-Industry Co-creation: Turning Consensus into Industry Assets
The symposium adopted an expert co-creation workshop model, sorting out risk substance lists and benchmarking regulations in China, the US, EU, and Japan across pharmaceuticals, food, medical devices, cosmetics, and toys. Professor Qian Xiaoming from Tiangong University pointed out that risk governance must take consumer safety as the endpoint, practicing reverse design and forward implementation; physical, chemical, and biological risks should be placed on the same map. Yan Huarong, chairman of the branch, proposed building a full-dimensional risk map and global regulatory information database with regular updates, and improving supply chain risk declarations, traceability, and responsibility definition.
If these consensuses are implemented, they will profoundly affect upstream-downstream collaboration. For suppliers, future contracts may need to specify risk substance lists and early warning values; for brands, establishing internal control standards higher than regulatory requirements will become key to differentiated competition.